Market Insights Health Pharmacies OTC Products

Skin Treatment (Pharmacies) - Japan

Japan

Revenue in the Skin Treatment market is projected to reach €0.91bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.97%, resulting in a market volume of €1.16bn by 2029.
In global comparison, most revenue will be generated in the United States (€3,045.00m in 2024).
In relation to total population figures, per person revenues of €7.39 are generated in 2024.

Key regions: Germany, Europe, South Korea, France, China

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Skin Treatment (Pharmacies) market in Japan is experiencing significant growth due to changing customer preferences and trends in the market. Customer preferences in the Skin Treatment (Pharmacies) market in Japan have shifted towards natural and organic products. Consumers are becoming more conscious about the ingredients they use on their skin and are seeking products that are free from harmful chemicals. This preference for natural and organic products is driving the demand for skincare products that are derived from natural sources and are environmentally friendly. In addition, there is a growing demand for skincare products that target specific skin concerns. Japanese consumers are increasingly looking for products that address issues such as acne, aging, and hyperpigmentation. This trend is driving the development of innovative skincare solutions that cater to these specific needs. Trends in the market include the rise of J-beauty, which refers to the Japanese approach to skincare. J-beauty emphasizes simplicity, minimalism, and the use of high-quality ingredients. Japanese skincare brands are known for their focus on research and development, resulting in products that are highly effective and gentle on the skin. This trend has gained popularity not only in Japan but also worldwide, with consumers seeking out Japanese skincare products for their proven efficacy. Another trend in the market is the increasing popularity of online sales channels. E-commerce platforms and social media have made it easier for consumers to access a wide range of skincare products, including those from international brands. This has led to a greater variety of products being available to Japanese consumers, further driving the growth of the market. Local special circumstances in Japan also contribute to the development of the Skin Treatment (Pharmacies) market. Japan has a strong culture of skincare and beauty, with a long history of traditional beauty practices. This cultural emphasis on skincare has created a demand for high-quality skincare products and treatments. Additionally, the aging population in Japan has led to an increased focus on anti-aging skincare products and treatments. Underlying macroeconomic factors such as a stable economy and increasing disposable income also play a role in the growth of the Skin Treatment (Pharmacies) market in Japan. As consumers have more disposable income, they are willing to invest in skincare products that meet their specific needs and preferences. The stable economy provides a favorable environment for businesses to thrive and innovate in the skincare market. Overall, the Skin Treatment (Pharmacies) market in Japan is developing due to changing customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The demand for natural and organic products, targeted skincare solutions, and J-beauty products is driving the growth of the market. The availability of online sales channels and the cultural emphasis on skincare also contribute to the development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.